Antipsychotic Drugs Opposite to Metabolic Risk: Neurotransmitters, Neurohormonal and Pharmacogenetic Mechanisms Underlying with Weight Gain and Metabolic Syndrome

Important sources of metabolic diseases such as obesity and metabolic syndrome are significantly more prevalent in patients treated with antipsychotic drugs than the general population and they not only reduce the quality of life but also significantly reduce the life expectancy, being important ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Milano, Walter, De Rosa, Michele, Milano, Luca, Capasso, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722531/
https://www.ncbi.nlm.nih.gov/pubmed/23894259
http://dx.doi.org/10.2174/1874205X01307010023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722531/
https://www.ncbi.nlm.nih.gov/pubmed/23894259
http://dx.doi.org/10.2174/1874205X01307010023

Ejemplares similares